Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 1,130,501 | 1,131,500 | +999 | $76.58M | $80.39M | 21.94% | +$3.81M |
| UroGen Pharma Ltd.(URGN) | 1,673,420 | 1,673,420 | 0 | $30.09M | $61.58M | 16.80% | +$31.49M |
| Trevi Therapeutics, Inc.(TRVI) | 2,144,844 | 2,144,844 | 0 | $25.59M | $40.00M | 10.92% | +$14.41M |
| Candel Therapeutics, Inc.(CADL) | 3,497,948 | 3,497,948 | 0 | $17.21M | $36.03M | 9.83% | +$18.82M |
| Puma Biotechnology, Inc.(PBYI) | 4,131,299 | 4,131,299 | 0 | $26.40M | $33.50M | 9.14% | +$7.11M |
| Jade Biosceinces Inc | 786,760 | 986,760 | +200,000 | $11.05M | $21.93M | 5.98% | +$10.87M |
| Bicara Therapeutics | 643,382 | 643,381 | -1 | $12.80M | $19.10M | 5.21% | +$6.31M |
| Karyopharm Therapeutics Inc.(KPTI) | 287,826 | 1,518,113 | +1,230,287 | $1.60M | $14.83M | 4.05% | +$13.23M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 2,839,674 | 2,839,674 | 0 | $11.76M | $12.95M | 3.53% | +$1.19M |
| Cybin D/B/A Helus Pharma(HELP) | 1,540,266 | 1,540,266 | 0 | $7.39M | $10.18M | 2.78% | +$2.79M |
| Protara Therapeutics, Inc.(TARA) | 1,752,115 | 1,752,115 | 0 | $9.13M | $6.69M | 1.83% | -$2.44M |
| Aura Biosciences, Inc.(AURA) | 595,744 | 929,077 | +333,333 | $3.99M | $6.60M | 1.80% | +$2.61M |
| LeonaBio, Inc.(LONA) | 634,539 | 634,539 | 0 | $6.52M | $5.83M | 1.59% | -$691.6K |
| Verastem, Inc.(VSTM) | 1,469,153 | 1,469,153 | 0 | $7.79M | $5.61M | 1.53% | -$2.17M |
| Whitehawk Therapeutics, Inc.(WHWK) | 1,139,363 | 1,139,363 | 0 | $3.93M | $5.22M | 1.42% | +$1.29M |
| Q32 Bio Inc.(QTTB) | 315,052 | 216,171 | -98,881 | $2.02M | $2.75M | 0.75% | +$731.4K |
| enGene Therapeutics Inc.(ENGN) | 0 | 1,271,257 | +1,271,257 | $0 | $2.20M | 0.60% | +$2.20M |
| Jasper Therapeutics, Inc.(JSPR) | 1,411,492 | 1,438,159 | +26,667 | $1.24M | $604.0K | 0.16% | -$638.1K |
| BioAtla, Inc.(BCAB) | 5,406,345 | 108,126 | -5,298,219 | $865.0K | $447.6K | 0.12% | -$417.4K |
| Yarrow Bioscience Inc(YARW) | 1,425 | 1,425 | 0 | $855 | $926 | 0.00% | +$71 |
| Cardiff Oncology, Inc.(CRDF) | 1,762,084 | 0 | -1,762,084 | $2.85M | $0 | — | -$2.85M |
| Terns Pharmaceuticals Inc | 1,746,264 | 0 | -1,746,264 | $92.06M | $0 | — | -$92.06M |
| X4 Pharmaceuticals, Inc.(XFOR) | 234,039 | 0 | -234,039 | $966.6K | $0 | — | -$966.6K |